Biomerica discloses going-concern substantial doubt due to insufficient cash to fund operations for the next twelve months.
SEC EDGAR, 2026-10-15: 10-Q — "substantial doubt"
Biomerica discloses going-concern substantial doubt due to insufficient cash to fund operations for the next twelve months.
Company: BIOMERICA INC (BMRA) Filed: 2026-10-15, 10-Q Phrase: "substantial doubt" — "These factors raise substantial doubt about our ability to continue as a going concern within twelve months following the issuance date of these financial statements." What the filing says: Biomerica reports that its existing cash and cash equivalents of approximately $2,733,000 as of August 31, 2026, are insufficient to fund its operations and meet its obligations over the next twelve months. The company has an accumulated deficit of approximately $58,175,000 and incurred a net loss of $1,232,000 for the three months ended August 31, 2026. While the company raised gross proceeds of approximately $2,231,000 in an August 2026 private placement and has a $250,000,000 replacement shelf registration statement declared effective on October 7, 2026, it must secure additional near-term financing, increase sales, or reduce expenses to continue as a going concern. Two ways it goes: A. The company secures additional debt or equity financing or achieves profitable operations to sustain its business. B. The company fails to obtain sufficient capital or generate cash flows and is forced to delay, reduce, or cease its operating activities. Next date: none named Watch: SEC filings or public announcements detailing new capital raises, strategic transactions, or a turn to positive operating cash flow.